Nabaltec (XTRA:NTG) Stock Cheapens As Margin Squeeze Clouds Recovery

Nabaltec stock has drifted over the past week even as investors continue to treat it as a value play, yet the latest quarterly numbers tell a more nuanced story. The headline is profitability. Q2 2026 basic earnings per share landed at €0.29 on revenue of €56.079m, and trailing net profit margin sits at 4.1%, lower than the 6.3% margin a year earlier. For a specialty chemicals producer, that squeeze on earnings power is what really matters. It is the tension you need to weigh against the low P/E and discounted cash flow upside case.

Is Nabaltec at €12.75 a genuine mispricing given a P/E of 13.8x against richer peers and a DCF marker of €40.39, or is the weaker 4.1% margin a warning sign? Compare that apparent discount with the detailed assumptions in our valuation analysis for Nabaltec

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs. Q2 2025): €56.079m vs. €51.782m (change of about 8.3%)
• Net Income (Excl. Extra Items, Q2 2026 vs. Q2 2025): €2.558m vs. €3.113m (decline of about 17.8%)
• Basic EPS (Q2 2026 vs. Q2 2025): €0.29 vs. €0.35 (decline of about 17.1%)
• Trailing Net Profit Margin (Last 12 Months vs. Prior Year): 4.1% vs. 6.3% (margin compression of about 2.2 percentage points)

Prefer clear visuals instead of scrolling through dense earnings tables and margin figures for Nabaltec? Get a full view of the company at a glance, including how its valuation compares in context, with the interactive company report for Nabaltec.

Nabaltec bull case hinges on utilization recovery

Bulls argue that Nabaltec has done the heavy lifting on CapEx, so a volume recovery should now translate cleanly into better margins and earnings. The current margin profile does not yet prove that out. Revenue of €56.079m in Q2 2026 is higher than a year earlier, yet net income excluding extra items moved from €3.113m to €2.558m and basic EPS from €0.35 to €0.29. Trailing net profit margin of 4.1% versus 6.3% a year earlier points to weaker fixed cost absorption despite the new capacity being in place. Any improvement in order intake for Functional Fillers or signs of bottoming in Specialty Aluminas have not yet translated into higher group profitability. The balance sheet and liquidity support the recovery thesis, but the key milestone of visible margin stabilization is still missing.

Nabaltec bear case focuses on margin compression risk

Bears focus on demand volatility, underutilized capacity and energy exposure keeping margins under pressure. The latest numbers give that view some backing. Nabaltec shows higher quarterly revenue than a year ago, yet net income excluding extra items and EPS both move lower, and trailing net profit margin compresses from 6.3% to 4.1%. That gap suggests pricing, mix, energy or raw material costs are absorbing a bigger share of the value created, while new hydroxide and boehmite capacity has not yet lifted earnings quality. The short order visibility that management has previously highlighted means this weaker margin level could persist if volumes do not improve. Structural pressure in Specialty Aluminas and competition from lower priced imports also look consistent with the current profitability profile rather than contradicted by it.

Compare how that weaker 4.1% margin stacks up against the recovery story bulls see for Nabaltec, then check whether analysts think the stock at €12.75 already reflects those risks and opportunities. See the consensus price target analysis for Nabaltec

Stay Ahead With Simply Wall St

If Nabaltec's mix of a 4.1% margin and a P/E of 13.8x has you weighing whether the current share price offers enough compensation for the risks, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and wait for your preferred entry point. Once you are invested, use the Portfolio Command Center to cut through day to day noise and focus on the most important changes to your holdings. For the longer term, tap into the Community to see how other investors are thinking about catalysts, risks and valuation. This helps you surface potential red flags or upside triggers early and stay ahead of the market.

Seeking Alternatives Beyond Nabaltec Now

Fresh stock ideas can move from quiet to breakout before most investors even notice. Consider using any first-mover edge while it is available and before they are widely recognized by the market.

• Explore early momentum in quality income plays and scan a curated field of companies with resilient cash flows through the 426 dividend fortresses
• Identify under the radar growth stories that still trade at compressed valuations by running through the hand picked 615 high quality undiscovered gems
• Strengthen your watchlist with companies that have robust finances and limited downside risk by filtering with the curated list of solid balance sheet and fundamentals stocks (425 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com